An Unusual View From the Supply Side of Addiction
Harvard University does a deep dive on the supply side of opioid addiction.
Controlled-Release Medication Could Improve Outcomes in Addiction Treatment
Researchers at VCU have formulated a drug that works better than methadone or buprenorphine at treating opioid use disorder.
Can Dopamine Homeostasis Be Achieved?
Is it possible that the restoration of a person’s dopamine homeostasis, through administration of tailored neuronutrients, could free them from all addictions in one masterful and definitive stroke?
Novo Nordisk to Test GLP-1 Drugs Against Addiction
Novo Nordisk, maker of Ozempic and Wegovy, says they will start testing GLP-1 drugs for use in treating addiction.
The Profit Potential in the Opioid Epidemic
A journal for pharmaceutical investors takes a look at the profit potential in treating opioid use disorders.
Preventing Relapse During Recovery From Opioid Use Disorder
Researchers at the University of Maryland team up to study the genetics of relapse during recovery from opioid use disorder.